Context Ureteral stent-related symptoms (SRSs) are very common and may potentially
influence the quality of life and functional capacity of patients. It remains unclear whether …

Phosphodiesterase type 5 inhibitors (PDE5i) is the only approved oral treatment for erectile
dysfunction (ED) in the US, and alternative management remains necessary when this …

Objectives: To compare the therapeutic efficacy, adverse events (AEs), and patient
preference in elderly patients with overactive bladder (OAB) receiving different combinations …

Background Bladder anticholinergics are the most widely used drugs to treat overactive
bladder (OAB) but can contribute to cumulative anticholinergic burden, which may be …

Objectives This study investigates the efficacy and adverse events of beta‐3 agonists and
antimuscarinic agents for managing overactive bladder syndrome in Sjogren syndrome …

Aims: Pressure in the bladder, which is a high compliance organ, is only slightly elevated to
a considerable filling volume during storage. Although cystometry off-line offers mean …

The prevalence and severity of overactive bladder increase with age, and mirabegron is an
approved treatment for this condition. This meta-analysis systematically evaluated the …

Introduction This study aimed to assess overactive bladder (OAB) treatment patterns and
factors associated with effectiveness and persistence. Methods A prospective, longitudinal …

Aims The management of overactive bladder (OAB) involves lifestyle changes and
conservative measures in the first instance with the use of liquid/dietary advice, weight loss …

The overactive bladder (OAB) is one of the most important clinical conditions in functional
urology for children and adults and а socially significant disease. About 18 million adults in …